Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

gadofosveset trisodium

The trisodium salt form of gadofosveset, an injectable, intravascular, amphiphilic gadolinium-based contrast agent (GBCA) used with magnetic… Expand
National Institutes of Health

Related topics

Related topics

7 relations

Broader (4)

Contrast MediaGadoliniumOrganometallic Compoundsgadofosveset

Narrower (2)

MS 325Vasovist
gadofosveset trisodium 244 MILLIGRAM In 1 MILLILITER INTRAVENOUS INJECTION [Vasovist]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
3.0-T whole-heart coronary magnetic resonance angiography: comparison of gadobenate dimeglumine and gadofosveset trisodium
Gadolinium enhanced coronary magnetic resonance angiography (MRA) at 3 T appears to be superior to non-contrast methods… Expand
  • table 2
  • table 1
  • table 3
  • table 4
  • table 5
2012
2012
Magnetic resonance VIBE venography using the blood pool contrast agent gadofosveset trisodium--an interrater reliability study.
PURPOSE In this study, image quality of leg veins and vena cava inferior was scored by independent raters using the new… Expand
2012
2012
Gadofosveset trisodium‐enhanced abdominal perforator MRA
To compare image quality including the number of perforators visualized, vessel contrast ratios, and vessel sharpness with blood… Expand
2012
2012
Towards Endometriosis Diagnosis by Gadofosveset-Trisodium Enhanced Magnetic Resonance Imaging
Endometriosis is defined as the presence of endometrial tissue outside the uterus. It affects 10–15% of women during reproductive… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2010
2010
Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: Multicenter intraindividual crossover comparison.
OBJECTIVE This prospective multicenter intraindividual crossover study was designed to compare gadobenate dimeglumine and… Expand
  • table 1
  • figure 1—62
  • table 4
  • figure 2—73
2010
2010
Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T.
RATIONALE AND OBJECTIVES Gadofosveset trisodium is a blood-pool contrast agent (BPA) that shows a less pronounced r1 relaxivity… Expand
2009
2009
First‐pass and steady‐state magnetic resonance angiography of the thoracic vasculature using gadofosveset trisodium
To compare a high‐resolution, ECG‐gated, motion‐compensated, steady‐state magnetic resonance angiography (SS‐MRA) of the thoracic… Expand
Highly Cited
2007
Highly Cited
2007
First-Pass Whole-Body Magnetic Resonance Angiography (MRA) Using the Blood-Pool Contrast Medium Gadofosveset Trisodium: Comparison to Gadopentetate Dimeglumine
Objectives:To evaluate gadofosveset trisodium for first-pass magnetic resonance angiography (MRA) in the setting of whole-body… Expand
2006
2006
Preclinical Safety Assessment of Vasovist (Gadofosveset trisodium), a New Magnetic Resonance Imaging Contrast Agent for Angiography
Objectives:Vasovist (EPIX Pharmaceuticals and Schering AG) is a newly developed blood pool contrast agent for magnetic resonance… Expand
Highly Cited
2003
Highly Cited
2003
MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial.
PURPOSE To evaluate the dose response and safety of gadofosveset trisodium-enhanced magnetic resonance (MR) angiography compared… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE